Business
Australian government backs psychedelic drug clinical trials to treat mental illness – The Guardian
$15m grant comes despite TGA’s failure to reschedule MDMA and psilocybin from a prohibited substance to a controlled medicine
The use of magic mushrooms, ecstasy and other psychedelic drugs to treat mental illnesses, including depression and post-traumatic stress disorder, may be a step closer in Australia, with clinical trials given a $15m grant.
Despite international evidence suggesting the medicinal effectiveness of psychedelic drugs to treat mental health conditions, the Australian Therapeutic Drug Association last month made an interim decision against rescheduling MDMA and psilocybin from a prohibited substance (schedule…
-
Noosa News22 hours agoTwo teenagers and two adults rushed to hospital in life-threatening conditions after shocking Lawnton house fire
-
Noosa News24 hours agoA secret scheme and plans to expel former leaders — here’s what we’ve heard from Queensland’s inquiry into the CFMEU
-
Business23 hours agoTop brokers name 3 ASX shares to buy next week 23 November 2025
-
Noosa News23 hours agoFatal traffic crash, Noosa – Sunshine Coast